---
figid: PMC9025507__biomedicines-10-00845-g003
pmcid: PMC9025507
image_filename: biomedicines-10-00845-g003.jpg
figure_link: /pmc/articles/PMC9025507/figure/biomedicines-10-00845-f003/
number: Figure 3
figure_title: ''
caption: Schematic diagram of the noradrenergic (NA) pathway from the LC to various
  regions, such as the neocortex, pallidal regions, thalamus, hypothalamus, hippocampal
  formation, brainstem, and cerebellum. The thickness of the arrow indicates the degree
  of connectivity. A1—primary auditory cortex; ACC—anterior cingulate cortex; ARC—arcuate
  nucleus; BLA—basolateral amygdala; CN—cochlear nucleus; CRN—caudal raphe nuclei;
  DG—dentate gyrus; DRN—dorsal raphe nuclei; EW—Edinger–Westphal nucleus; FN—facial
  nucleus; HGN—hypoglossal nucleus; LDT—laterodorsal tegmental nuclei; LHb—lateral
  habenula; M1—primary motor cortex; MNG—midline nuclear group; MOB—main olfactory
  bulb; mPFC—medial prefrontal cortex; MS—medial septum; NVmt—trigeminal motor nucleus;
  NVsnpr—trigeminal sensory nucleus; OFC—orbitofrontal cortex; ONC—oculomotor nuclear
  complex; PeFLH—lateral hypothalamus/perifornical area; PPT—pedunculopontine tegmental
  nuclei; PVN—paraventricular nucleus; RVLM—rostral ventrolateral medulla; SI—substantia
  innominate; SN—salivatory nuclei; VA—ventral anterior nuclei; VLPO—ventrolateral
  preoptic area; VPL—ventral posterolateral nucleus; VPM—ventral posteromedial nucleus;
  vSub—ventral subiculum.
article_title: Alteration of Neural Pathways and Its Implications in Alzheimer’s Disease.
citation: Sujin Kim, et al. Biomedicines. 2022 Apr;10(4):845.
year: '2022'

doi: 10.3390/biomedicines10040845
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI

keywords:
- Alzheimer’s disease
- neural pathways
- neural circuits
- neurodegeneration
- connectome

---
